Vertex Pharmaceuticals Inc
VRTX
$366.54-9.09 (-2.42%)
Aug 8, 2025, 4:00 PM
Financials
| 52Week High | 519.88 | 52Week Low | 364.66 |
| Beta | 0.44 | Current Ratio Annual | 2.69 |
| Current Ratio Quarterly | 2.52 | Gross Margin TTM | 86.11 |
| Market Cap | 96.31B | Net Profit Margin TTM | 31.86 |
| Operating Margin TTM | 34.36 | Price To Book | 5.61 |
| Price To Earnings TTM | 26.48 | Price To Free Cash Flow TTM | 27.52 |
| Price To Sales TTM | 8.43 | Quick Ratio Annual | 2.23 |
| Quick Ratio Quarterly | 2.00 | Return On Assets TTM | 15.87 |
| Return On Equity TTM | 22.14 | Return On Investment TTM | 22.03 |
| Revenue Growth3Y | 13.31 | Revenue Growth5Y | 21.50 |
| Revenue Growth Quarterly Yoy | 12.06 | Revenue Growth TTMYoy | 10.46 |
| Revenue Per Share TTM | 44.11 |
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 1526 | 181 | 169 | 596 | 547 | 175 | 240.69M | $109.37B |
| Jun 30, 2025 | 907 | 44 | 74 | 328 | 342 | 131 | 35.49M | $14.83B |
| Change | 619(41%) | 137(76%) | 95(56%) | 268(45%) | 205(37%) | 44(25%) | 205.20M(85%) | $94.55B(86%) |